Suppr超能文献

疫苗过敏评估和管理在专科绿色通道咨询诊所。

Vaccine allergy evaluation and management at the specialized Green Channel Consultation Clinic.

机构信息

National Centre for Immunobiologicals Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Clin Exp Allergy. 2012 Jul;42(7):1088-96. doi: 10.1111/j.1365-2222.2012.03985.x.

Abstract

BACKGROUND

Suspected vaccine allergy may be a cause of incomplete or delayed vaccination. Patients at risk of adverse reactions or suspected contraindications need specialized consultation about subsequent vaccinations.

OBJECTIVE

To analyse consultancy results for patients at risk of allergic reactions to vaccines as evaluated by the Green Channel University Hospital Immunization Consultancy Clinic.

METHODS

A review of cases of allergic reactions to vaccines or contraindications due to underlying diseases or sensitization to vaccine components submitted to the Green Channel was carried out. Analysed data included detailed clinical reaction history, skin and in vitro allergy testing with vaccine components, recommendations for vaccination and outcome of subsequent vaccine administrations.

RESULTS

A total of 519 cases, 370 referred for previous local or systemic reactions to vaccines, mostly cutaneous, and 149 sent for suspected contraindications were evaluated. Skin testing was performed on 152 patients, specific IgE determination in 37 subjects and patch testing in 173 cases. After consultation, 442 (85%) subjects were advised to continue vaccination, with personalized precautions (premedication, or alternative brand, or administration in graded doses) for 200 of them. Among the 352 (80%) patients vaccinated as per Green Channel instructions, 33 subjects (9.3%) reported mild allergic or non-specific symptoms and one (0.3%) urticaria with bronchospasm.

CONCLUSION AND CLINICAL RELEVANCE

Even though vaccine allergy occurs very rarely, a safe procedure for immunization can be applied, through specialized allergy consultancy, for most subjects with suspected allergy to vaccines, and who could be potentially excluded from vaccination for risk of adverse reactions.

摘要

背景

疑似疫苗过敏可能是疫苗接种不完全或延迟的原因。有发生不良反应风险或疑似禁忌证的患者需要就后续疫苗接种进行专门咨询。

目的

分析大学医院免疫接种咨询诊所绿色通道评估的有疫苗过敏反应风险的患者的咨询结果。

方法

对提交给绿色通道的疫苗过敏反应或因基础疾病或对疫苗成分致敏而导致的禁忌证病例进行回顾性分析。分析的数据包括详细的临床过敏反应史、疫苗成分的皮肤和体外过敏试验、疫苗接种建议以及随后疫苗接种的结果。

结果

共评估了 519 例病例,其中 370 例因先前局部或全身疫苗反应(主要为皮肤),149 例因疑似禁忌证而被转诊。对 152 例患者进行了皮肤试验,37 例患者进行了特异性 IgE 测定,173 例患者进行了斑贴试验。咨询后,建议 442 例(85%)患者继续接种疫苗,其中 200 例患者采取个性化预防措施(预先用药、替代品牌或分级剂量接种)。根据绿色通道的建议接种疫苗的 352 例(80%)患者中,33 例(9.3%)报告有轻度过敏或非特异性症状,1 例(0.3%)出现荨麻疹伴支气管痉挛。

结论和临床意义

尽管疫苗过敏极为罕见,但通过专门的过敏咨询,可对大多数疑似疫苗过敏且有发生不良反应风险而可能被排除在疫苗接种之外的患者,采用安全的免疫接种程序。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验